GATA2 and neoplasm: Compared with patients with low GATA2 expression, patients with high GATA2 expression had significantly decreased risk of tumor recurrence (H.R. = 0.63, 95% CI = 0.43∼0.90, p = 0.012) and patient death (H.R. = 0.67, 95% CI = 0.47∼0.95, p = 0.026).